Project Grant HT94252410708
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$4.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
This Project Grant award from the Department of the Army Medical Command provides $3,940,561 to fund the "Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery in Persons with Chronic Spinal Cord Injury: The BO2ST Trial" project under the Military Medical Research and Development program (CFDA 12.420). The award period is from September 30, 2022 through September 29, 2026. The project aims to investigate the extent to which daily acute intermittent hypoxia...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $482,708.00 to the University of Florida to conduct research on combined therapeutic acute intermittent hypoxia and respiratory-triggered diaphragm pacing to restore breathing function in chronic cervical spinal cord injury. The project will run from September 30, 2025 to September 29, 2028. The University of Florida, a major public...
This federal Project Grant award of $449,391.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research on combinatorial respiratory rehabilitation approaches to enhance breathing recovery after cervical spinal cord injury (SCI). The research aims to maximize breathing recovery after chronic, incomplete cervical SCI by pairing therapeutic acute...
The University of Florida's Division of Sponsored Research received a $718,988 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year project aims to test a novel oxygen release therapeutic for the preservation of spinal cord tissue resulting from spinal cord injury ischemia. Key products and services to be delivered include: Obtaining IACUC and institutional safety approvals, purchasing equipment and animals,...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $437,621.00 to Marquette University to conduct research on combined therapeutic acute intermittent hypoxia and respiratory-triggered diaphragm pacing to restore breathing function in chronic cervical spinal cord injury. The project aims to advance medical solutions for military personnel and the broader public by exploring innovative approaches to treating...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $595,245 to the University of Florida to conduct research on using normobaric oxygen therapy to mitigate secondary damage and preserve breathing function after spinal cord injury. The key objectives are to determine if normobaric oxygen therapy, initiated acutely after...
This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
The Department of the Army Medical Command awarded a $711,403 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a project titled "A Noninvasive Neurotrophic Factor Treatment to Repair the Injured Spinal Cord" with a period of performance from October 1, 2024 to September 30, 2027. This project grant supports advanced biomedical research focused...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
The University of Florida was awarded a $762,501 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support preclinical evaluation of an emergency-ready therapy for spinal cord injury from August 1, 2022 to July 31, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...